Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06891547 · ClinicalTrials.gov registry record · NA

Radicle Spark for Women™ 24: Assessing the Impact of Health and Wellness Products on Sexual Health and Related Health Outcomes

A NA study, sponsored by Radicle Science.

Completed
Registry status
NA
Development phase
600
Enrollment target

NCT06891547: Completed NA study, sponsored by Radicle Science.

NCT06891547 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 600 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06891547, a NA study, has completed, sponsored by Radicle Science.

COMPLETED
Registry status
NA
Development phase
600 participants
Enrollment target

Study Summary

A randomized, double-blind, placebo-controlled, direct-to-consumer study assessing the impact of health and wellness products on sexual health and related health outcomes.

Primary Outcome

Mean difference in sexual health score as assessed by Patient Reported Outcome Measurement System (PROMIS) Full Profile Sexual Function and Satisfaction Survey (Female) (where lower scores correspond to lower sexual function and satisfaction)

Interventions

  • DIETARY_SUPPLEMENT Spark Placebo Control 5.1
  • DIETARY_SUPPLEMENT Spark Active Study Product 5.1 Usage

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2025-02-20
Est. Completion 2025-08-11
Phase NA
Radicle Science

55 total trials

What the finished NCT06891547 record still lists

NCT06891547 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).

The record links to 0 conditions, and to 2 interventions - of which Spark Placebo Control 5.1 is the first listed.

NCT06891547 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06891547 about?

NCT06891547 is a clinical study titled "Radicle Spark for Women™ 24: Assessing the Impact of Health and Wellness Products on Sexual Health and Related Health Outcomes". A randomized, double-blind, placebo-controlled, direct-to-consumer study assessing the impact of health and wellness products on sexual health and related health outcomes.

What is the current status of trial NCT06891547?

This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2025-02-20. Estimated completion is 2025-08-11.

What interventions are being tested in trial NCT06891547?

The interventions under investigation include: Spark Placebo Control 5.1 (DIETARY_SUPPLEMENT), Spark Active Study Product 5.1 Usage (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06891547?

This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06891547's enrollment target sits among peer trials

600 162nd of 2000 higher than 1,827 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06891547, the US trial registry maintained by the National Library of Medicine. NCT06891547 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.